Daily FNArena News - Australia

Amcor has upgraded guidance and announced a new buyback, providing a pleasing outlook for the rest of FY21.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

During October the ASX200 outperformed most developed markets peers, with the financial and technology sectors leading the way

Performance fees at JO Hambro made a welcome return for Pendal Group at the end of FY20 and continued delivery of stronger net flows could be the necessary re-rating catalyst.

Heightened interest in infection prevention should be of benefit to Nanosonics in the wake of the pandemic, although rising cases in the short term create risks.

Brambles has a defensive business with a dominant global position and is now more confident in the FY21 outlook.

Ansell’s products are readily tailored to the waves of coronavirus sweeping the world so it is no surprise guidance for FY21 has already been upgraded.

Western Areas has downgraded guidance amid lower grades as its Forrestania mines come to the end of their lives. Hence, the future lies with Odysseus.

ResMed has plenty of irons in the fire, well placed to grow from increases in home health care despite the likelihood ventilator sales will decline rapidly from the peak during the pandemic.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments